$2.03
-0.0299-1.45%
Last update: May 11, 11:07 AM
BioNexus Gene Lab Earnings Estimates, EPS & Revenue | NASDAQ:BGLC
BioNexus Gene Lab (BGLC) is scheduled to report Q1 earnings on May 22, 2026.
Earnings Date
Apr 14
EPS
$-0.522
Quarterly Revenue
$483.76K
Annual Revenue
(as of Dec 31)
(as of Dec 31)
$7.42M
BioNexus Gene Lab Earnings History
Analyze the earnings history of BioNexus Gene Lab using advanced sorting and filters.
Loading calendar...
BioNexus Gene Lab (BGLC) Earnings Per Share
The chart below shows BioNexus Gene Lab's reported EPS compared to analyst estimates over recent quarters.
BioNexus Gene Lab (BGLC) Revenue
The chart below shows BioNexus Gene Lab's reported revenue compared to analyst estimates over recent quarters.
FAQ
When is BioNexus Gene Lab (NASDAQ:BGLC) reporting earnings?
BioNexus Gene Lab (BGLC) is scheduled to report earnings on May 22, 2026. The last reported earnings were for reported on April 14, 2026 for Q4.
What were the latest earnings per share (EPS) for BioNexus Gene Lab (NASDAQ:BGLC)?
The Actual EPS was $-0.52, which missed the estimate of $0.00.
What were BioNexus Gene Lab’s (NASDAQ:BGLC) revenues?
The Actual Revenue was $483.76K, which beat the estimate of $0.00.
